IPP Bureau
U.S. FDA grants De Novo Clearance for Philips IVC filter removal laser sheath
By IPP Bureau - December 23, 2021
Philips’s CavaClear is intended to safely ablate tissue to remove embedded IVC filters
Manipal Hospital Delhi opens advanced cancer care centre
By IPP Bureau - December 23, 2021
The hospital has recently launched Radionuclide therapy
U.S. FDA approves Novartis Leqvio to lower cholestrol
By IPP Bureau - December 23, 2021
With two maintenance doses a year, Leqvio is the first and only FDA-approved small interfering RNA (siRNA) therapy for LDL-C (bad cholesterol) reduction1
Windlas Biotech appoints Shailendra Rastogi as CBO
By IPP Bureau - December 22, 2021
He has over 22 years of experience in pharmaceutical sales & business development
Piramal Pharma takes a minority stake in Yapan Bio
By IPP Bureau - December 22, 2021
The investment in Yapan Bio allows Piramal Pharma Solutions to broaden its service offerings in the fast-growing biologics CDMO space
World Health Organisation SAGE recommends use of Novavax Covid-19 vaccine as booster
By IPP Bureau - December 22, 2021
SAGE recommends additional third dose of the vaccine administered to immunocompromised persons
Merck acquires Chord Therapeutics to expand its neuroinflammatory pipeline
By IPP Bureau - December 22, 2021
Acquisition provides opportunity to develop cladribine in generalized Myasthenia Gravis (gMG) and Neuromyelitis Optica Spectrum Disorder (NMOSD)
Novartis to acquire Gyroscope Therapeutics for up to US $ 1.5 bn
By IPP Bureau - December 22, 2021
Acquisition will add GT005 to the Novartis portfolio, an investigational, one-time gene therapy currently in Phase 2 for the treatment of people living with Geographic atrophy
Thermo Fisher Scientific updates its Covid-19 panel to detect Omicron
By IPP Bureau - December 22, 2021
The TaqMan SARS CoV-2 Mutation Panel is compatible with real-time PCR instruments already commonly used in laboratories around the world
Sputnik Light booster after Sputnik V effective against Omicron: Study
By IPP Bureau - December 22, 2021
Sputnik Light as a booster significantly increases virus neutralizing activity against Omicron based on sera 2-3 months after revaccination
AquaCentric Therapy opens up for treatment of autism care
By IPP Bureau - December 22, 2021
Autism spectrum disorder affects 78 million people and families worldwide
A 39-year-old patient with Covid-19 was saved with ECMO support
By IPP Bureau - December 22, 2021
Patient with acute Covid-19 infection treated at BGS Gleneagles Global Hospital
Stelis commissions vaccine facility in Bengaluru
By IPP Bureau - December 21, 2021
The company has started manufacturing the Sputnik Light vaccine
Sandoz submits Biologics License Application for proposed biosimilar trastuzumab to US FDA
By IPP Bureau - December 21, 2021
Trastuzumab is monoclonal antibody used to treat human epidermal growth factor receptor 2 positive (HER2+) breast cancer and metastatic gastric cancers
CDSCO increases shelf life of Covaxin
By IPP Bureau - December 21, 2021
The approval of shelf life extension is based on the availability of additional stability data, which was submitted to the CDSCO
